{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:09:01Z","timestamp":1789186141715,"version":"build-2803163510"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7893-26","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:11:29Z","timestamp":1788819089000},"source":"Crossref","is-referenced-by-count":0,"title":["Usefulness of the C-reactive Protein Level as a Substitute for the Erythrocyte Sedimentation Rate when Calculating the BACES Score of Patients with &lt;i&gt;Mycobacterium Avium&lt;\/i&gt; Complex Pulmonary Disease"],"prefix":"10.2169","author":[{"given":"Shunnosuke","family":"Tanaka","sequence":"first","affiliation":[{"name":"First Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhito","family":"Ushiki","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Kimoto","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miwa","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumpei","family":"Akahane","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ikuyama","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hanaoka","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kim JY, Kwak N, Yim JJ. The rise in prevalence and related costs of nontuberculous mycobacterial diseases in South Korea, 2010-2021. Open Forum Infect Dis 9: ofac649, 2022.","DOI":"10.1093\/ofid\/ofac649"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Namkoong H, Kurashima A, Morimoto K, et al. Epidemiology of pulmonary non-tuberculous mycobacterial disease, Japan. Emerg Infect Dis 22: 1116-1117, 2016.","DOI":"10.3201\/eid2206.151086"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Winthrop KL, Marras TK, Adjemian J, et al. Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. managed care health plan, 2008-2015. Ann Am Thorac Soc 17: 178-185, 2020.","DOI":"10.1513\/AnnalsATS.201804-236OC"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Jhun BW, Moon SM, Jeon K, et al. Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study. Eur Respir J 55: 1900798, 2020.","DOI":"10.1183\/13993003.00798-2019"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hwang JA, Kim S, Jo KW, Shim TS. Natural history of <i>Mycobacterium avium<\/i> complex lung disease in untreated patients with stable course. Eur Respir J 49: 1600537, 2017.","DOI":"10.1183\/13993003.00537-2016"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Harada K, Hagiya H, Funahashi T, Koyama T, Kano MR, Otsuka F. Trends in the nontuberculous mycobacterial disease mortality rate in Japan: a nationwide observational study, 1997-2016. Clin Infect Dis 73: e321-e326, 2021.","DOI":"10.1093\/cid\/ciaa810"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Daley CL, Iaccarino JM, Lange C Jr, et al. Treatment of non-tuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Clin Infect Dis 71: e1-e36, 2020.","DOI":"10.1093\/cid\/ciaa241"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Haworth CS, Banks J, Capstic T, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacteria pulmonary disease (NTM-PD). Thorax 72: ii1-ii64, 2017.","DOI":"10.1136\/thoraxjnl-2017-210927"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kim HJ, Kwak N, Hong H, et al. BACES score for predicting mortality in nontuberculous mycobacterial pulmonary disease. Am J Respir Crit Care Med 203: 230-236, 2021.","DOI":"10.1164\/rccm.202004-1418OC"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kim HJ, Song MJ, Kwon BS, et al. Usefulness of the BACES score in nontuberculous mycobacterial pulmonary disease for various clinical outcomes. Sci Rep 13: 7495, 2023.","DOI":"10.1038\/s41598-023-33782-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ushiki A, Tanaka S, Yamanaka M, et al. Effect of multidrug therapy on the prognosis of <i>Mycobacterium avium<\/i> complex pulmonary disease. Sci Rep 14: 4438, 2024.","DOI":"10.1038\/s41598-024-55135-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y. Prognostic factors of 634 HIV-negative patients with <i>Mycobacterium avium<\/i> complex lung disease. Am J Respir Crit Care Med 185: 575-583, 2012.","DOI":"10.1164\/rccm.201107-1203OC"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Park HJ, Kim YJ, Yim JJ, Kwak N. Prognostic serum biomarkers in non-tuberculous mycobacterial pulmonary disease. J Infect Chemother 29: 1005-1007, 2023.","DOI":"10.1016\/j.jiac.2023.06.017"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48: 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Feldman M, Aziz B, Kang GN, Opondo MA, Belz RK, Sellers C. C-reactive protein and erythrocyte sedimentation rate discordance: frequency and causes in adults. Transl Res 161: 37-43, 2013.","DOI":"10.1016\/j.trsl.2012.07.006"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yan M, Fraser B, McArthur E, Mehrabi M, Brode SK, Marras TK. External validation of the BACES score in Canadian patients with nontuberculous mycobacterial pulmonary disease. Chest 165: 521-528, 2024.","DOI":"10.1016\/j.chest.2023.10.006"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340: 448-454, 1999.","DOI":"10.1056\/NEJM199902113400607"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Pepys MB, Gideon MH. C-reactive protein: a critical update. J Clin Invest 111: 1805-1811, 2003.","DOI":"10.1172\/JCI200318921"},{"key":"19","unstructured":"19. Costenbader KH, Chibnik LB, Schur PH. Discordance between erythrocyte sedimentation rate and C-reactive protein measurements: clinical significance. Clin Exp Rheumatol 25: 746-749, 2007."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Im Y, Hwang NY, Kim K, Kim H, Kwon OJ, Jhun BW. Impact of time between diagnosis and treatment for nontuberculous mycobacterial pulmonary disease on culture conversion and all-cause mortality. Chest 161: 1192-1200, 2022.","DOI":"10.1016\/j.chest.2021.10.048"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Bemer P, Peuchant O, Guet-Revillet H, et al. Management of patients with pulmonary mycobacteriosis in France: a multicenter retrospective cohort study. BMC Pulm Med 21: 333, 2021.","DOI":"10.1186\/s12890-021-01701-5"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Boyle DP, Zembower TR, Qi C. Relapse versus reinfection of <i>Mycobacterium avium<\/i> complex pulmonary disease. Patient characteristics and macrolide susceptibility. Ann Am Thorac Soc 13: 1956-1961, 2016.","DOI":"10.1513\/AnnalsATS.201605-344BC"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7893-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:29:48Z","timestamp":1789183788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7893-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":22,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7893-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7893-26"}}